| EKWAX | FEGOX | EKWAX / FEGOX | |
| Total Expense Ratio | 1.09 | 1.91 | 57% |
| Annual Report Gross Expense Ratio | 1.17 | 1.91 | 61% |
| Fund Existence | 28 years | 23 years | - |
| Gain YTD | 8.522 | 9.220 | 92% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.52B | 5.77B | 26% |
| Annual Yield % from dividends | 1.10 | 0.63 | 174% |
| Returns for 1 year | 151.90 | 118.61 | 128% |
| Returns for 3 years | 255.74 | 172.12 | 149% |
| Returns for 5 years | 225.61 | 165.17 | 137% |
| Returns for 10 years | 535.89 | 377.13 | 142% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSITX | 64.67 | 0.94 | +1.47% |
| Goldman Sachs Small Cp Val Insghts Instl | |||
| BUFOX | 16.90 | 0.21 | +1.26% |
| Buffalo Early Stage Growth Fd | |||
| PCCOX | 68.92 | 0.44 | +0.64% |
| T. Rowe Price U.S. Equity Research I | |||
| TFFAX | 9.98 | 0.06 | +0.60% |
| Templeton Foreign Adv | |||
| DRLAX | 8.95 | -0.07 | -0.78% |
| BNY Mellon Developed Markets RE Scs - A | |||